DATA AVAILABILITY STATEMENT:
The data that support the findings of this study are available from the
authors are available upon reasonable request.
KEY CLINICAL MESSAGE:We report on the
successful use of chemotherapy for treatment of stage 2B testicular
seminoma in a carrier of the Leber’s Hereditary Optic Neuropathy 11778
mitochondrial mutation. Neurotoxic chemotherapy may not prompt disease
conversion.